AN experimental vaccine implant to treat skin cancer has begun early trials in humans, as part of a growing effort to train the immune system to fight tumours, researchers said.
The approach, which was shown to work in lab mice in 2009, involves placing a fingernail-sized sponge under the skin where it reprogrammes a patient’s immune cells to find cancerous melanoma cells and kill them.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!